| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $69.6M | — | +99.3% |
| Cost of Revenue | $68.6M | — | +127.6% |
| Gross Profit | $1.0M | — | -78.3% |
| R&D Expense | $4.2M | — | +39.5% |
| SG&A Expense | $4.5M | — | +18.6% |
| Operating Income | -$9.7M | — | -238.7% |
| Interest Expense | $252K | — | -15.0% |
| Pre-tax Income | -$9.0M | — | -336.6% |
| Income Tax | $7K | — | — |
| Net Income | -$9.3M | — | -488.1% |
| EPS (Basic) | -$0.10 | — | -400.0% |
| EPS (Diluted) | -$0.10 | — | -400.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.3M | +12.5% | +130.5% |
| Accounts Receivable | $46.5M | +21.1% | +13.9% |
| Inventory | $75.7M | +49.5% | +145.7% |
| Current Assets | $238.4M | +32.0% | +66.5% |
| Total Assets | $491.0M | +15.2% | +57.6% |
| Current Liabilities | $368.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $22.3M | — | +331.6% |
| Capital Expenditures | $11.8M | — | -7.1% |
| Investing Cash Flow | -$11.8M | — | -19.0% |
| Financing Cash Flow | $11.3M | — | +90.9% |
| Free Cash Flow | $10.5M | — | +147.1% |
| +109.8% |
| Long-term Debt | $7.7M | +85.8% | +85.2% |
| Total Liabilities | $388.8M | +22.8% | +101.7% |
| Stockholders' Equity | $105.2M | -6.7% | -12.9% |